VanEck Pharmaceutical ETF Rating → This AI Trade Machine Made 1,729%* (With 89% Wins) (From Prosper Trading Academy) (Ad) Free PPH Stock Alerts $86.80 +0.28 (+0.32%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy2.60Holdings in PPH have an aggregate rating of Moderate Buy based on 213 analyst ratings issued in the past year covering 23 companies (91.0% of the portfolio).PPH Aggregate Price Target$95.419.92% UpsideHigh Prediction$113.88Average Prediction$95.41Low Prediction$79.50Holdings in PPH have an aggregate price target of $95.41 and a range of $79.50 to $113.88 covering 23 companies (91.0% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 PPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.05%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings9.70%NVONovo Nordisk A/S$126.85+0.8%2 of 5 stars2.75$133.60 5.3%8Upcoming Earnings6.48%JNJJohnson & Johnson$146.14-0.5%5 of 5 stars2.46$175.86 20.3%136.28%MRKMerck & Co., Inc.$131.20+0.4%5 of 5 stars2.58$131.33 0.1%12Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage5.81%ABBVAbbVie$159.62-4.6%5 of 5 stars2.77$177.43 11.2%13Earnings ReportNews CoverageHigh Trading Volume5.51%AZNAstraZeneca$75.17+0.2%2 of 5 stars2.57$81.00 7.8%7Analyst ReportShort Interest ↑Analyst RevisionNews Coverage4.81%CORCencora$240.88+0.5%4 of 5 stars2.63$218.22 -9.4%8Upcoming Earnings4.74%MCKMcKesson$543.30+0.6%5 of 5 stars2.83$533.50 -1.8%12Dividend AnnouncementAnalyst UpgradeAnalyst Revision4.60%HLNHaleon$8.45+0.6%3 of 5 stars2.605Upcoming EarningsShort Interest ↓Positive News4.57%SNYSanofi$49.13-0.5%3 of 5 stars2.40$55.00 11.9%5Short Interest ↓Analyst RevisionNews Coverage4.42%PFEPfizer$25.40+0.6%5 of 5 stars2.38$36.33 43.0%16Upcoming EarningsDividend AnnouncementNews Coverage4.39%GSKGSK$41.11+0.5%2 of 5 stars2.405Upcoming EarningsShort Interest ↑News Coverage4.24%BMYBristol-Myers Squibb$44.85+0.3%5 of 5 stars2.11$60.00 33.8%19Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage3.91%ZTSZoetis$158.42+3.3%5 of 5 stars3.00$218.00 37.6%7Upcoming EarningsAnalyst Report2.77%TEVATeva Pharmaceutical Industries$13.81+4.2%1 of 5 stars2.70$13.78 -0.2%10Positive News1.82%VTRSViatris$11.57+0.9%0 of 5 stars1.33$11.00 -4.9%31.03%JAZZJazz Pharmaceuticals$109.46+1.9%5 of 5 stars2.85$195.08 78.2%13Upcoming EarningsNews Coverage0.98%CTLTCatalent$55.92+0.2%3 of 5 stars2.15$52.46 -6.2%13Analyst ReportNews CoveragePositive News0.82%ELANElanco Animal Health$13.26+1.7%4 of 5 stars2.57$16.71 26.1%7Short Interest ↑0.64%PRGOPerrigo$31.94+2.1%5 of 5 stars3.00$40.67 27.3%3News Coverage0.59%OGNOrganon & Co.$18.55+0.7%5 of 5 stars2.50$21.80 17.5%4Upcoming EarningsNews Coverage0.48%BHCBausch Health Companies$8.71+1.0%4 of 5 stars2.33$12.50 43.5%3Upcoming EarningsAnalyst ReportShort Interest ↓Positive News0.31%PDCOPatterson Companies$25.77-0.1%5 of 5 stars2.25$32.56 26.3%8Analyst Report This page (NASDAQ:PPH) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
